🇺🇸

US SEC Filing Intelligence

· daily

Global High-Priority Regulatory Events — August 04, 2026

The August 4, 2026 filing batch reveals a market bifurcated between aggressive strategic repositioning and persistent distress. Key themes include a wave of private credit BDC tender offers (5 filings) signaling a sector-wide liquidity management trend, significant M&A activity in India (8 deals) across auto components, real estate, and e-commerce, and several high-profile delistings including Electronic Arts' $210/share take-private and SOLAI Ltd's failure to meet listing standards. Financial performance is mixed: Bed Bath & Beyond shows a remarkable revenue turnaround (+28% YoY) but widening losses, while Nykaa and Worth Peripherals deliver strong profit growth. Distress signals are prominent with Quadrant Televentures' insolvency extension, VSEE Health's imminent delisting, and DuPont's sharp swing to a net loss. Insider activity is limited, but capital allocation is active with multiple buybacks and tender offers. The overall picture is one of active portfolio reshaping, with investors rotating capital toward growth and away from structurally challenged assets.

50 high priority 50 total filings
· daily

US SEC Filings Daily Market Digest — August 04, 2026

Today's filings reveal a market bifurcated between strong operational performers and those facing significant headwinds. Palantir, ADM, and Quanta Services posted exceptional growth, with Palantir's revenue surging 92.8% YoY and ADM's adjusted EPS nearly doubling. However, a wave of mixed results and guidance cuts from companies like Smith & Nephew, Ingredion, and Toyota highlights persistent margin pressure and demand uncertainty. The most critical development is the $5.3 billion acquisition of Lantheus Holdings by Curium, which, alongside the pending Prologis/SEGRO deal and Abra Financial's SPAC merger, signals robust M&A activity. Insider activity is notably absent from most filings, but capital allocation trends are clear: aggressive buybacks from Gartner and BBVA contrast with a major debt refinancing by Southern Co. The biotech sector presents a stark dichotomy, with IDEAYA's positive Phase 3 results juxtaposed against Lipocine's failed trial and Lisata's drastic workforce reduction. Overall, the digest points to a 'show-me' market where execution is rewarded and guidance is being scrutinized.

17 high priority 33 medium 50 total filings
· daily

S&P 500 Consumer Discretionary Sector SEC Filings — August 04, 2026

The S&P 500 Consumer Discretionary sector is showing a clear divergence between resilient travel demand and a softening quick-service restaurant (QSR) environment. Booking Holdings reported a 118% surge in net income and 8% revenue growth, though forward guidance for room night growth points to a deceleration. In contrast, McDonald's U.S. comparable sales growth slowed sharply to +0.8% from +2.5% a year ago, prompting a leadership change. Carvana saw a significant insider buying event from a director ($1.54M) alongside multiple C-suite sales under 10b5-1 plans, creating a mixed signal on management conviction. Capital allocation trends are aggressive: Booking Holdings is deepening its stockholders' deficit through buybacks, while Aptiv used a $1.9B spin-off dividend to aggressively deleverage. The period-over-period data reveals margin expansion at Aptiv (+160 bps) and strong earnings growth at Booking, but the overall consumer discretionary landscape is cautious, with negative guest counts at McDonald's and mixed insider activity across the portfolio.

16 high priority 4 medium 20 total filings
· daily

S&P 500 Healthcare Sector SEC Filings — August 04, 2026

The S&P 500 Healthcare sector is exhibiting a clear bifurcation in Q2 2026: top-tier innovators like Vertex and Amgen are delivering double-digit revenue growth (12.5% and 10% YoY, respectively) and expanding margins, while legacy pharma giants like Pfizer and Merck face earnings headwinds from large acquisition-related charges and asset impairments. A wave of aggressive M&A, particularly in biotech (Gilead's $11.2B in acquired IPR&D, Merck's Terns acquisition), is driving significant GAAP losses and depleting cash reserves, signaling a high-stakes bet on pipeline replenishment. Capital allocation patterns are diverging sharply, with Vertex and IDEXX aggressively buying back shares (combined ~$1.5B in H1 2026), while Amgen and Pfizer pause repurchases to fund deals. Insider activity is mixed but notable: Gilead's CEO sold ~$1.96M under a 10b5-1 plan, while Medtronic's top brass received substantial equity awards, suggesting confidence in long-term strategy. The most critical development is the sector-wide margin pressure from rising SG&A (Vertex +37% YoY) and R&D investment, even as top-line growth remains resilient.

30 high priority 6 medium 36 total filings
· daily

US Earnings Financial Results SEC Filings — August 04, 2026

The Q2 2026 earnings season reveals a bifurcated market where top-line growth is often masking significant margin compression and earnings quality deterioration. Of the 50 filings analyzed, 12 companies reported revenue growth exceeding 20% YoY, yet 8 of those saw net income decline or losses widen, driven by soaring operating expenses, restructuring charges, and inventory build-ups. The most prominent theme is a 'growth at any cost' dynamic, particularly in tech-enabled and industrial sectors, where companies like Palantir (+92.8% revenue) and Paymentus (+28.8%) are exceptions, while others like Voyager Technologies (+15.5% revenue but -45.7% gross profit) and Shoals Technologies (+47.4% revenue but -12.4% net income) are burning cash to grow. The energy sector is a standout positive, with EOG Resources more than doubling net income on surging crude revenues. A critical portfolio-level pattern is the aggressive use of debt and equity financing to fund operations and acquisitions, with Hut 8 raising $7.7B in new debt and Kratos raising $1.35B in equity, signaling a potential liquidity crunch if growth stalls. Insider activity is notably absent from the enriched data, but capital allocation trends show a clear preference for share repurchases over dividends, with Credit Acceptance and Matson aggressively buying back stock, while Pfizer and others are cutting costs. The key takeaway for investors is to look beyond revenue growth and scrutinize cash flow, operating leverage, and the sustainability of capital structures.

50 high priority 50 total filings
· daily

US Executive Compensation Proxy SEC Filings — August 04, 2026

This digest of 9 proxy filings reveals a bifurcated landscape: capital-intensive firms like AAR Corp are executing aggressive growth strategies (record $3.3B sales, 4 acquisitions) but facing cash flow strain and high debt, while micro-cap entities like Salarius Pharmaceuticals and FREVS are in existential transitions—one relying on milestone-driven warrant exercises to fund clinical trials, the other liquidating entirely. A notable theme is the prevalence of 'mixed' sentiment in filings with material financial stakes (AAR, Salarius), reflecting tension between operational momentum and balance sheet fragility. Insider activity is sparse across the set, but the absence of selling in AAR (despite a 29% EPS beat) is a modest positive signal. The most actionable catalysts are Salarius's September 27 special meeting (potential $17.5M cash infusion) and FREVS's liquidation timeline, which creates a defined path to capital return. Governance patterns are standard, with no activist campaigns or shareholder revolts flagged, though RENN Fund's leadership void from Murray Stahl's passing warrants monitoring for strategic drift.

9 high priority 9 total filings
· daily

US IPO Pipeline SEC S-1 Filings — August 04, 2026

The IPO pipeline for August 4, 2026, is dominated by a single new SPAC registration, Luminous Acquisition, which seeks to raise capital for a blank-check business combination, reflecting continued but measured SPAC activity. The filing shows a mixed sentiment due to the inherent risks of SPAC structures, including warrant redemption terms and expiration of rights if no deal is completed. DuPont de Nemours, while filing an S-4 for a debt exchange offer, is not a new IPO but provides critical context on capital markets activity and corporate financial health, with a sharp YoY swing from net income of $703 million in 2024 to a net loss of $779 million in 2025. The DuPont filing also highlights a 1-for-3 reverse stock split, signaling potential efforts to maintain listing standards or improve share price perception. No insider trading activity or forward-looking guidance was provided in these filings, limiting trend analysis but underscoring the importance of monitoring deal timelines and financial performance. The overall pipeline shows a mix of speculative SPAC issuance and established corporate debt restructuring, with no traditional operating company IPOs in this batch.

2 high priority 2 total filings
· daily

US SEC Trading Suspension Halt Orders — August 04, 2026

The USA Trading Suspensions stream for August 4, 2026, reveals two contrasting events: Bed Bath & Beyond is undergoing a transformative turnaround with strong revenue growth and a planned Nasdaq listing, while VSEE Health faces an imminent delisting due to a critically low stock price. Period-over-period data shows Bed Bath & Beyond's revenue surged 28% YoY and orders grew 117%, but losses widened, indicating a high-cost recovery phase. VSEE Health's delisting is a terminal regulatory event with no appeal stay, highlighting severe financial distress. The key theme is the divergence between a company executing a strategic pivot and one failing to meet basic listing standards, both generating significant trading suspension risks. Insider activity and forward-looking data are limited in these filings, but the operational metrics and regulatory timelines provide actionable intelligence for investors monitoring suspension events.

2 high priority 2 total filings
· daily

US Executive Officer Management Changes SEC — August 04, 2026

This digest covers 44 filings related to USA executive and director changes, with a significant concentration of CEO transitions and strategic leadership shifts. A key theme is the high number of CEO departures (at least 8) across diverse sectors, including Fuel Tech, TELA Bio, Better Home & Finance, 3D Systems, Matthews International, Dave & Buster's, and Steel Dynamics, often part of planned successions. The filings also reveal a mix of financial health signals: while some companies like Marqeta and PAMT CORP show improving profitability, others like Angi Inc. and Lumen Technologies report declining revenues and significant impairments. A notable pattern is the use of inducement equity awards for new executives, indicating a competitive talent market. The data also highlights several risk factors, including a major workforce reduction at Lisata Therapeutics, a sharp deceleration in guidance at Marqeta, and a pending CEO vacancy at 3D Systems, which create actionable investment signals.

44 high priority 44 total filings
· daily

US Corporate Board Director Changes SEC Filings — August 04, 2026

The 44 filings for August 4, 2026, reveal a significant wave of leadership transitions across the US market, with 30+ companies reporting CEO, CFO, or board changes. The most critical developments are concentrated in the small-to-mid-cap healthcare and technology sectors, where several companies are undergoing forced or strategic restructurings. Notable period-over-period trends from the earnings reports embedded in these filings show a mixed picture: while Marqeta and Better Home & Finance posted strong revenue growth (32% and 38% YoY respectively), others like Lumen Technologies (-9% YoY) and Angi Inc. (-11% YoY) are contracting. A clear pattern of insider departures amid financial distress is emerging, with Lisata Therapeutics (72% workforce reduction) and Better Home (founder CEO ousted, ongoing losses) signaling deep operational challenges. The market is also seeing a wave of planned CEO successions at large caps (Steel Dynamics, McDonald's, Johnson & Johnson), which are generally viewed as neutral-to-positive due to orderly transitions. The most actionable intelligence lies in the diverging fortunes of companies like Marqeta (strong growth but sharp guidance deceleration) versus the distressed restructurings at Lisata and Better Home, where insider moves and forward-looking statements point to significant downside risk.

44 high priority 44 total filings
· daily

USA Insider Trading Pulse — August 04, 2026

The August 4, 2026, insider trading pulse reveals a market characterized by significant insider selling, particularly by major shareholders and C-suite executives, signaling caution in several sectors. Notable large-scale disposals include a $96.4M sale by Abu Dhabi Investment Authority in Jersey Mike's Subs and a $3.85M sale by L1 Capital in Anteris Technologies, both bearish signals for their respective companies. Conversely, insider buying is concentrated in financials and select industrials, with a TSMC VP making a $73K purchase and a director at Alliance Resource Partners buying $78K, suggesting selective value opportunities. The data shows a clear divergence: while routine director awards and option exercises are common, the material, open-market selling by informed parties outweighs buying, creating a cautious overall tone. Key themes include insider profit-taking in high-growth tech and consumer names, and a rotation into perceived value in regional banks and energy. The lack of forward-looking guidance changes in the filings limits catalyst visibility, but the insider activity itself serves as a powerful, real-time signal for portfolio managers to scrutinize positions in companies with heavy insider selling.

41 high priority 9 medium 50 total filings
· daily

US Merger & Acquisition SEC Filings — August 04, 2026

The US M&A and takeover landscape during this period is characterized by a wave of SPAC activity, strategic corporate divestitures, and a landmark take-private transaction. Key themes include SPACs extending deadlines (Pyrophyte, Valuence) and financing mergers (Columbus, Calisa), alongside significant portfolio reshaping by operating companies (Resideo, Griffon, Digital Ally/Cycurion). The most material event is Electronic Arts' $210/share acquisition by a consortium led by PIF and Silver Lake, marking a major delisting and a shift in gaming industry ownership. Period-over-period data reveals a focus on deleveraging (Resideo's $900M debt repayment, Griffon's $181M cash infusion) and strategic pivots to higher-growth or core businesses (Digital Ally's exit from video solutions, Resideo's spin-off of ADI). Insider activity is limited, but sponsor participation in Calisa's subscription agreement signals confidence. Overall, the period reflects a mix of cautious extension strategies in the SPAC market and decisive value-unlocking actions by established companies.

14 high priority 14 total filings
· monthly

US Pre-Market SEC Filings Roundup — August 04, 2026

Overnight filings reveal a bifurcated market environment where industrial and commodity-linked companies are delivering robust growth, while several healthcare and tech names face headwinds. Palantir Technologies reported staggering 92.8% YoY revenue growth and raised guidance, while ADM's adjusted EPS surged 98% YoY, leading to upward revisions in full-year forecasts. Conversely, Ingredion and Smith & Nephew both cut guidance due to operational disruptions and product headwinds, respectively. Insider activity was mixed: a coordinated insider buying spree at SPAC East West Ave Acquisition Corp. contrasts with significant stock sales at Snowflake and New Oriental Education. Capital allocation trends show a strong preference for share repurchases, with DuPont, Grab, and Equinor announcing or executing buybacks. A notable pattern is the divergence between GAAP and adjusted earnings, with companies like Qnity Electronics and Eve Holding showing improved operational metrics but wider GAAP losses due to non-recurring items.

33 high priority 17 medium 50 total filings
· daily

S&P 500 Technology Sector SEC Filings — August 03, 2026

The August 3, 2026 SEC filings for the S&P 500 Technology sector reveal a stark divergence between high-growth AI-native companies and mature hardware/software firms. Palantir Technologies reported exceptional Q2 2026 results, with total revenue surging 93% YoY and U.S. commercial revenue skyrocketing 149% YoY, significantly outperforming the sector. The company raised its full-year guidance, signaling sustained momentum. In contrast, KLA Corporation, a semiconductor equipment maker, saw multiple top executives (CEO, CFO, SVP) engage in routine tax-withholding stock sales, indicating no insider conviction but no panic either. Datadog and CrowdStrike saw significant insider selling by directors and CEOs, respectively, under 10b5-1 plans, which may signal profit-taking at elevated valuations. Autodesk completed its acquisition of MaintainX, expanding its asset management capabilities. The overarching theme is a 'two-speed' tech market: AI/software leaders are accelerating, while legacy hardware and cybersecurity firms show insider caution. Portfolio-level trends highlight strong revenue growth in AI-adjacent software, but insider selling patterns suggest skepticism about sustaining current valuations.

12 high priority 1 medium 13 total filings
· daily

Nasdaq 100 Stocks SEC Filings — August 03, 2026

The August 3, 2026 filings for the NASDAQ-100 stream reveal a stark divergence between AI-driven growth and legacy/asset-heavy business models. Palantir's exceptional 93% YoY revenue growth and raised guidance underscore the AI boom, while Strategy Inc's massive unrealized digital asset losses highlight the volatility of crypto-heavy balance sheets. Insider activity is mixed, with a QUALCOMM HR executive selling and Intel insiders engaging in routine transactions. Capital allocation trends show aggressive ATM equity issuance by Strategy Inc to fund Bitcoin purchases and preferred dividends, while Gilead's 13F reveals a concentrated biotech investment portfolio. Sector themes point to AI monetization, crypto volatility, and insider activity patterns. Key catalysts include Palantir's Q3 earnings and continued Bitcoin price sensitivity for Strategy Inc.

5 high priority 3 medium 8 total filings
· daily

US Activist Hedge Fund Institutional SEC 13D 13G — August 03, 2026

The August 3, 2026, batch of 50 SEC filings reveals a landscape dominated by passive institutional position adjustments, with a few high-conviction activist campaigns and insider moves creating actionable opportunities. The most critical development is the escalation of activist campaigns at **Sonos Inc.** (Coliseum Capital upgraded to a 13D with a 15.3% stake) and **Tivic Health Systems/Valion Bio** (3i, LP demanding CEO removal), signaling imminent strategic shifts. A significant sector theme is the aggressive consolidation in the **renewable energy and biotech** spaces, highlighted by **O.Y. Nofar Energy** increasing its stake in **Ellomay Capital** to 75% and **CK Life Sciences** taking an 83.9% controlling stake in **TransCode Therapeutics**. On the institutional side, **Baillie Gifford & Co** and **Bank of America** are making notable sector rotations, with Baillie Gifford taking a massive 15.23% stake in **Bending Spoons S.p.A.** while slightly trimming **Nu Holdings**, and Bank of America establishing new passive positions in several small-cap biotechs and SPACs. The data shows a clear bifurcation: large, passive flows into growth/tech names versus concentrated, activist-driven value creation in underperforming assets. The lack of explicit forward-looking guidance in most filings suggests a period of quiet accumulation before catalysts, making the few activist events the primary near-term alpha drivers.

6 high priority 44 medium 50 total filings
· daily

S&P 500 Financials Sector SEC Filings — August 03, 2026

The S&P 500 Financials sector is showing a clear divergence between investment banking/trading powerhouses and traditional lenders/insurers. Goldman Sachs reported a stellar quarter with 39% revenue growth and doubling of EPS, driven by a 61% surge in Investment Banking and Market Making, while Progressive Corp faces mounting pressure from a 927% increase in net unrealized losses on its fixed-income portfolio due to rising rates. Insider activity is sending mixed signals: Capital One's President sold $2M in stock under a 10b5-1 plan, while Mitsubishi UFJ reduced its Morgan Stanley stake by $88M. Capital allocation patterns reveal aggressive buyback activity at Goldman Sachs ($9B in H1 2026) and a strategic preferred stock redemption at Northern Trust, signaling confidence in capital positions. The most critical development is the sharp deterioration in fixed-income portfolios across the sector, with Progressive's unrealized losses ballooning to $832M and Goldman Sachs recording a $944M other comprehensive loss, highlighting the impact of the rising rate environment on balance sheets.

5 high priority 2 medium 7 total filings
· daily

S&P 500 Energy Sector SEC Filings — August 03, 2026

The S&P 500 Energy sector is showing a clear bifurcation between upstream/production companies and midstream infrastructure operators. ExxonMobil's Q2 2026 earnings more than doubled YoY to $14.5B, driven by surging revenues and robust cash flow generation, while midstream giants Williams and ONEOK reported solid but more moderate growth, with adjusted EBITDA up 6% and 7% respectively. A significant strategic move is Williams' $5.5B acquisition of Momentum Midstream, signaling consolidation in the Haynesville basin. However, capital spending is surging across the sector—Williams' capex jumped 58% YoY—and cash flow from operations declined at Williams, raising concerns about free cash flow sustainability. Insider activity was concentrated at Kinder Morgan, where the entire C-suite exercised and withheld shares for taxes, a routine but notable event given the simultaneous $1.75B debt issuance. The sector is reinvesting heavily in growth, with shareholder returns (dividends, buybacks) still rising but at a slower pace than capital expenditures.

11 high priority 2 medium 13 total filings
· daily

S&P 500 Consumer Staples Sector SEC Filings — August 03, 2026

The Consumer Staples sector is showing a clear divergence between defensive growth and inflationary pressure. Clorox's Q4 FY26 earnings reveal significant acquisition-driven revenue growth (GOJO added ~10 points) but severe margin compression (-520 bps gross margin) and declining organic sales, pointing to a challenging operating environment. Insider activity is mixed but notable: Coca-Cola's CFO executed a large $13.3M sale (albeit after a pre-planned option exercise), while Hershey's 10% owner sold ~$1.15M under a 10b5-1 plan, signaling potential caution from key stakeholders. In contrast, Church & Dwight and McCormick are awarding phantom stock to executives, a neutral-to-slightly-bullish retention signal. The sector is experiencing a 'growth through M&A' theme, but the cost of integration and persistent inflation are eroding profitability. The delisting of matured debt for Philip Morris and Procter & Gamble is a non-event, confirming routine capital management. The key takeaway is that while top-line growth is achievable via M&A, organic volume and margin health remain under severe pressure, making stock selection critical.

9 high priority 1 medium 10 total filings
· daily

S&P 500 Industrials Sector SEC Filings — August 03, 2026

The seven filings for August 3, 2026, are exclusively from Honeywell International Inc. and its subsidiary, Honeywell Aerospace Inc., plus one from Republic Services, Inc. The dominant theme is a wave of insider transactions at Honeywell, characterized by the routine exercise and tax-withholding of restricted stock units (RSUs) by senior executives, including the CFO and the President/CEO of a key division. This pattern is typical of scheduled vesting events and does not signal a bearish shift in management sentiment. However, one notable outlier is a direct open-market sale by the President/CEO of Process Technologies, which warrants closer attention for potential conviction change. The Republic Services filing shows a director exercising RSUs, a standard non-cash event. The digest lacks period-over-period financial comparisons, forward-looking guidance, or capital allocation data, limiting the ability to identify broader sector trends. The primary actionable intelligence is the need to monitor Honeywell's upcoming earnings call for commentary on the Process Technologies division and to track any acceleration in insider selling across the broader industrial sector.

7 high priority 7 total filings